| Univariate analysis | Multivariate analysis | ||||||
---|---|---|---|---|---|---|---|---|
β | Odds ratio | 95% CI | p | β | Odds ratio | 95% CI | p | |
Preoperative recipient parameters | ||||||||
Age (years) | −0.002 | 0.998 | 0.967–1.029 | 0.893 |  |  |  |  |
Sex (female) | −0.087 | 0.916 | 0.500–1.680 | 0.777 |  |  |  |  |
Body mass index (kg·m-2) | −0.057 | 0.945 | 0.876–1.019 | 0.142 |  |  |  |  |
Psoas muscle index (mm2·m-2) | −0.004 | 0.996 | 0.993–0.999 | 0.017 | −0.004 | 0.996 | 0.993–0.999 | 0.019 |
Comorbidity | ||||||||
 Diabetes mellitus | −0.303 | 0.738 | 0.380–1.436 | 0.371 |  |  |  |  |
 Hypertension | −0.035 | 0.965 | 0.484–1.927 | 0.921 |  |  |  |  |
MELD score (point) | 0.042 | 1.042 | 1.019–1.066 | <0.001 |  |  |  |  |
CRRT | 0.923 | 2.516 | 1.323–4.784 | 0.005 | 0.710 | 2.034 | 1.004–4.125 | 0.049 |
Hepatocellular carcinoma | −0.473 | 0.623 | 0.350–1.108 | 0.107 |  |  |  |  |
 Beyond Milan criteria | −0.345 | 0.708 | 0.079–6.356 | 0.758 |  |  |  |  |
Hepatic decompensation | ||||||||
 Encephalopathy | −0.061 | 0.940 | 0.359–2.463 | 0.900 |  |  |  |  |
 Varix | −0.196 | 0.822 | 0.422–1.601 | 0.565 |  |  |  |  |
 Ascites | 0.478 | 1.613 | 0.929–2.803 | 0.090 |  |  |  |  |
Cardiac function | ||||||||
 Ejection fraction (%) | 0.036 | 1.036 | 0.973–1.104 | 0.267 |  |  |  |  |
 Diastolic dysfunction | 0.048 | 1.050 | 0.605–1.820 | 0.863 |  |  |  |  |
Laboratory variables | ||||||||
 Hemoglobin (g·dL-1) | −0.063 | 0.939 | 0.827–1.066 | 0.331 |  |  |  |  |
 WBC count (×109·L-1) | 0.009 | 1.009 | 0.965–1.054 | 0.701 |  |  |  |  |
 C-reactive protein to albumin ratio (%) | 0.439 | 1.551 | 1.198–2.007 | 0.001 |  |  |  |  |
 Neutrophil to lymphocyte ratio (%) | 0.052 | 1.053 | 1.020–1.087 | 0.002 | 0.032 | 1.032 | 1.000–1.066 | 0.048 |
 Platelet to lymphocyte ratio | 0.002 | 1.002 | 1.000–1.004 | 0.064 |  |  |  |  |
 Sodium (mEq·L-1) | −0.041 | 0.960 | 0.916–1.006 | 0.089 |  |  |  |  |
 Potassium (mEq·L-1) | 0.009 | 1.009 | 0.645–1.579 | 0.968 |  |  |  |  |
 Glucose (mg·dL-1) | −0.001 | 0.999 | 0.994–1.004 | 0.796 |  |  |  |  |
Intraoperative recipient parameters | ||||||||
Surgical duration (min) | 0.000 | 1.000 | 0.998–1.003 | 0.775 |  |  |  |  |
Post-reperfusion syndrome | 0.568 | 1.765 | 0.981–3.174 | 0.058 |  |  |  |  |
Mean vital sign values | ||||||||
 MBP (mmHg) | −0.008 | 0.992 | 0.963–1.022 | 0.601 |  |  |  |  |
 HR (beats·min-1) | 0.012 | 1.012 | 0.993–1.032 | 0.210 |  |  |  |  |
 CVP (mmHg) | 0.092 | 1.097 | 1.011–1.190 | 0.026 |  |  |  |  |
Mean lactate (mmol·L-1) | 0.036 | 1.036 | 0.971–1.107 | 0.286 |  |  |  |  |
Blood product transfusion (unit) | ||||||||
 Packed red blood cells | 0.038 | 1.039 | 1.014–1.064 | 0.002 |  |  |  |  |
 Fresh frozen plasma | 0.031 | 1.032 | 1.002–1.063 | 0.039 |  |  |  |  |
 Single donor platelets | 0.015 | 1.015 | 0.916–1.126 | 0.774 |  |  |  |  |
Hourly fluid infusion (mL·kg-1·h-1) | 0.016 | 1.016 | 0.997–1.035 | 0.094 |  |  |  |  |
Hourly urine output (mL·kg-1·h-1) | −0.250 | 0.779 | 0.589–1.029 | 0.079 |  |  |  |  |
Donor-graft parameters | ||||||||
Age (years) | 0.011 | 1.011 | 0.988–1.036 | 0.354 |  |  |  |  |
Sex (female) | 0.039 | 1.040 | 0.583–1.856 | 0.894 |  |  |  |  |
Body mass index (kg.m-2) | −0.003 | 0.997 | 0.911–1.091 | 0.945 |  |  |  |  |
GRWR (%) | 0.304 | 1.355 | 0.672–2.734 | 0.396 |  |  |  |  |
ABO-incompatible graft | 0.359 | 1.432 | 0.615 – 3.333 | 0.405 |  |  |  |  |
Graft ischemic time (min) | 0.001 | 1.001 | 0.998–1.004 | 0.653 |  |  |  |  |
Fatty change (%) | 0.025 | 1.025 | 0.993–1.059 | 0.125 |  |  |  |  |
Early postoperative parameters | ||||||||
Early allograft dysfunction | 1.420 | 4.136 | 2.255–7.586 | <0.001 | 1.199 | 3.315 | 1.721–6.388 | <0.001 |
Acute kidney injury | 0.421 | 1.523 | 0.866–2.680 | 0.144 |  |  |  |  |
Biliary stricture or leakage | 0.411 | 1.508 | 0.765–2.974 | 0.236 |  |  |  |  |
Mechanical ventilation duration (min) | 0.000 | 1.000 | 1.000 – 1.000 | 0.780 |  |  |  |  |
Acute graft rejection | -0.594 | 0.552 | 0.244 – 1.252 | 0.155 |  |  |  |  |